Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 15;7(7):3791-9.
eCollection 2014.

Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway

Affiliations

Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway

Zhenwang Tang et al. Int J Clin Exp Pathol. .

Abstract

Mouse aldo-keto reductase family 1 member B8 (AKR1B8) has the highest similarity to human aldo-keto reductase family 1 member B10 (AKR1B10), a secretory protein through lysosomes-mediated non-classical secretory pathway. To identify whether AKR1B8 is secreted through the same pathway, we carried out this study. Self-developed sandwich ELISA and western blot were used to detect AKR1B8 in cells and culture medium of CT-26 murine colon carcinoma cells. AKR1B8 releases in an independent manner to Brefeldin A, an inhibitor of ER-to-Golgi classical secretion pathway. Several factors, which are involved in the non-classical secretion pathway, such as temperature, ATP and calcium ion, regulated AKR1B8 secretion from mouse colorectal cancer cells CT-26. Lysosomotropic NH4Cl increased AKR1B8 secretion, and AKR1B8 was located in isolated lysosomes. Therefore, AKR1B8 is a new secretory protein through the lysosomes-mediated non-classical pathway.

Keywords: AKR1B8; Aldose reductase; aldose reductase family 1 member B8; non-classical pathway; secretion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preparations of AKR1B8 protein and antibody. A. Purification of AKR1B8 protein with different concentrations was analyzed by Coomassie blue staining. B. Purification of rabbit anti-AKR1B8 antibody was analyzed by Coomassie blue staining. C. Specificity of AKR1B8 antibody to AKR1B8 (FR1) and not to mAR and MVDP was analyzed by western blot.
Figure 2
Figure 2
AKR1B8 release from CT-26 cells. A. AKR1B8 secreted from CT-26 cells in medium was detected by western blot. B. AKR1B8 activity. Cells (1 × 107) as indicated were seeded into six-cm dishes overnight and then fed with 2 ml of serum-free medium for 30 min. Medium was collected and subjected to an enzyme activity assay as described in the Materials and methods section. *p < 0.01 vs Fresh Medium.
Figure 3
Figure 3
AKR1B8 secretes via a non-classical pathway. (A) Signal-peptide analyses in AKR1B8. Amino acid sequence of full-length mouse AKR1B8 was inputted into the SignalP 3.0 server (http://www.cbs.dtu.dk/services/SignalP/), and neural networks (NN) and hidden Markov models (HMM) were run. Both SignalP-NN (A) and SignalP-HMM (B) results showed no signal peptide in the AKR1B8 sequence. (B) Brefeldin (A) cells (2.5 × 105) were cultured in six-well plates overnight and then expose to the ER-to-Golgi protein transport inhibitor brefeldin A at 10 μg/ml in fresh serum-free medium for 8 h. Medium was collected for Western blotting. Vimentin was detected by Western blotting as a positive control.
Figure 4
Figure 4
AKR1B8 secretion is affected by nonclassical secretory pathway-related factors. A. Temperature. cells (2.5 × 105) were seeded into six-well plates overnight and then exposed to the temperature (°C) indicated for 30 min. The cells were fed with fresh serum-free medium at the same temperature for 30 min, and medium was collected for Western blotting as described in the Materials and methods. B. ATP and Calcium. Cells (2.5 × 105) were incubated in six-well plates overnight and then exposed to 1 mM Ca2+ ions or 2 µM Ionomycin in serum-free medium for 2 h. At 30 min before harvest, ATP (1 mM) was added or not, and the medium was subjected to Western blot analysis.
Figure 5
Figure 5
Lysosomes are involved in AKR1B8 secretion. A. AKR1B8 secretions were enhanced by NH4Cl treatment. B. AKR1B8 was present inside the isolated lysosomes by western blotting analysis.

References

    1. Gallego O, Ruiz FX, Ardevol A, Dominguez M, Alvarez R, de Lera AR, Rovira C, Farres J, Fita I, Pares X. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc Natl Acad Sci U S A. 2007;104:20764–20769. - PMC - PubMed
    1. Petrash JM. All in the family: aldose reductase and closely related aldo-keto reductases. Cell Mol Life Sci. 2004;61:737–749. - PMC - PubMed
    1. Petrash JM, Harter TM, Srivastava S, Chandra A, Bhatnagar A, Srivastava SK. Structure-function studies of FR-1. A growth factor-inducible aldo-keto reductase. Adv Exp Med Biol. 1999;463:435–443. - PubMed
    1. Srivastava SK, Das B, Hair GA, Gracy RW, Awasthi S, Ansari NH, Petrash JM. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties. Biochim Biophys Acta. 1985;840:334–343. - PubMed
    1. Srivastava S, Watowich SJ, Petrash JM, Srivastava SK, Bhatnagar A. Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry. 1999;38:42–54. - PubMed

Publication types

LinkOut - more resources